Cat.No. | Name | Information |
---|---|---|
M1881 | Tozasertib | Tozasertib (VX-680, MK-0457) is a potent and selective pan-Aurora kinase inhibitor active against all Bcr/Abl proteins. |
M1752 | Aliertib (MLN 8237) | Alisertib (MLN8237) is a second-generation, orally bioavailable, highly selective Aurora kinase A inhibitor with IC50 of 61 nM. |
M1663 | AZD1152-HQPA | AZD1152-HQPA (Barasertib) is a highly potent and selective inhibitor of Aurora with Ki values of 0.36 and 1369 nM for Aurora B and Aurora A respectively. |
M20247 | WAY-636982 | WAY-636982 is a Aurora kinase A inhibitor. |
M20246 | WAY-636900 | WAY-636900 is a Aurora kinase A inhibitor. |
M20245 | WAY-635767 | WAY-635767 is a Aurora kinase A inhibitor |
M20244 | WAY-635764 | WAY-635764 is a Aurora kinase A inhibitor. |
M20238 | WAY-634704 | WAY-634704 is a Aurora kinase A inhibitor. |
M20235 | WAY-632963 | WAY-632963 is a Aurora kinase A inhibitor. |
M20066 | WAY-298668 | WAY-298668 altering the lifespan of a eukaryotic organism |
M13591 | Cenisertib | Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. |
M3221 | PF-03814735 | PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.